SHANDONG XINHUA (00719): Aspirin enteric-coated tablets add new specifications and pass generic drug consistency evaluation.

SHANDONG XINHUA (00719) announced that the company recently received the approval notification of the supplementary application for the issuance of Aspirin Enteric-Coated Tablets (100mg) from the National Medical Products Administration. This product has passed the evaluation of generic drug quality and efficacy consistency. Aspirin Enteric-Coated Tablets are used in the treatment of the blood system, mainly for unstable angina (as part of standard treatment); acute myocardial infarction (as part of standard treatment); prevention of recurrent myocardial infarction; after arterial vascular surgery or interventional surgery, such as coronary artery bypass grafting, percutaneous coronary intervention; prevention of transient ischemic attack (TIA) and prevention of stroke after early symptoms have appeared.